Message from the Director
|
|
Stan Gerson, MD
Director, Case Comprehensive Cancer Center
|
|
The Case Comprehensive Cancer Center (Case CCC), the remarkable powerhouse consortium of Case Western Reserve University, University Hospitals and Cleveland Clinic, represents all cancer research and most of the cancer care in Northeast Ohio. Our membership includes 400 cancer investigators and over 6,000 cancer healthcare professionals. We support the lives of 15,000 new cancer cases each year, or about 70% of the cases that occur among the four million individuals in the region.
The Case CCC catchment area includes 15 counties in Northeast Ohio and we seek to understand and address the challenges across the diverse communities we serve. We care for traditionally underserved populations, which include African Americans in Cleveland, Akron and Youngstown, the rural areas of Ashtabula County and the Amish in Geauga County. Poverty is a major concern and a daily reality for many in these communities, linked to elevated levels of chronic stress, tobacco use and obesity. We continue to develop strategies to address these significant challenges and their impact on cancer risk.
|
|
Gmail users: to ensure you're always viewing the entire newsletter, check at the bottom of the email to see if the newsletter has been "clipped" and click "view entire message" if so.
|
|
|
|
16th Annual “The Race” 5K and 1-Mile Run raises $70,000 for cancer research at the Case Comprehensive Cancer Center
|
Each year, “The Race” attracts thousands of participants to Legacy Village in Lyndhurst, OH on Mother’s Day, empowering children and families to make a difference in the lives of those touched by breast cancer by raising money and awareness for research and early detection. Originated in 2004 by Joshua and Danielle Berns, then 13 and 11 years old, respectively, the family-focused event is a tradition kept alive today by their parents, Jonathan and Patti Berns.
|
|
In 2019, “The Race” selected the Case Comprehensive Cancer Center (Case CCC) as the beneficiary of 100 percent of participant registration fees and donations as the event’s operating costs are covered by private donors. As a result of the event, the Case CCC received $70,000 in support of innovative breast cancer research. Jonathan and Patti Berns recently visited the Case CCC to present the funds to Director Stan Gerson, MD. Case CCC investigators are consistently working toward finding cancer cures, and thanks to “The Race” they will be supported through availability of new pilot grant awards. This year's Race will take place on Sunday, May 10, 2020 and once again benefit the research efforts of the Case CCC, the coordinating body for all major cancer research activities across Northeast Ohio.
|
|
United States Cancer Death Rate Drops - Case CCC Leaders Comment
|
Earlier this week,
the American Cancer Society published a study reviewing cancer incidence and mortality data and projecting numbers of new cancer cases and deaths in the United States in 2020 in an effort to estimate the contemporary cancer burden. Of particular note in the study, the cancer death rate experienced its largest decline to-date from 2016 to 2017, a fall of two-point-two percent.
|
|
|
|
Stan Gerson, MD, Director of the Case Comprehensive Cancer Center and the National Center for Regenerative Medicine at Case Western Reserve University spoke with Cleveland's newsradio
WTAM 1100 regarding the findings. He noted that unhealthy food choices, alcohol use and obesity remain major causes of cancer, requiring more lifestyle changes from the public. Dr. Gerson also shared that much of rate decline can be attributed to immunotherapy which trains a person's immune system to fight cancer.
Ted Teknos, MD, President of the Seidman Cancer Center at University Hospitals,
also spoke to Cleveland's 19 News
about the encouraging data, noting that genetic therapy has been crucial to keeping patients alive.
|
|
|
|
Recommended Reading: NCI Cancer Currents Blog
|
"Cancer cells go to great lengths to sustain their growth, survival, and spread. Now scientists believe they have uncovered yet another way in which cancer cells may support their own uncontrolled growth. The findings, published November 27 in Cell, support a different way of thinking about cancer, said
Peter Scacheri, PhD, of Case Western Reserve University."
|
|
Mon, Jan 13
Shared Resources Directors Meeting
12p WRB 1-422D
GMI Seminar Series
Stefanie Avril, MD
12p WRB 1-422D
|
|
Tues, Jan 14
Cancer Impact Lecture
1p NE1-205
|
|
Weds, Jan 15
Biomedical Innovation and Entrepreneur Club
4-6p BRB 932
CanSUR Program Applications Due
|
|
Thurs, Jan 16
D
evelopmental Therapeutics Journal Club
9a NE6-218
Immunology Journal Club
Lingzi Hong
12p WRB 5-136
Molecular Biology and Microbiology Seminar
1p SOM W203
|
|
Fri, Jan 17
Taussig Cancer Institute Grand Rounds
Wendy Harpham, MD
8a CA5-120
Cancer Center Seminar Series
Michel Tremblay, PhD
12p WRB Auditorium
|
|
|
Mon, Jan 20
CWRU Closed for Martin Luther King Jr. Day
|
|
Tues, Jan 21
Cancer Impact Lecture
1p NE1-205
Cancer Drug Discovery and Resistance
3p WRB 1-422D
|
|
Weds, Jan 22
Cancer Center Special Seminar
Ksenia Matlawska-Wasowska, PhD
4p WRB 2-136
|
|
Thurs, Jan 23
D
evelopmental Therapeutics Journal Club
9a NE6-218
Immunology Journal Club
Micah Harland
12p WRB 5-136
Molecular Biology and Microbiology Seminar
1p SOM W203
|
|
Fri, Jan 24
Taussig Cancer Institute Grand Rounds
8a CA5-120
UH Seidman Cancer Center Grand Rounds
8a Wearn 137
Cancer Center Seminar Series
Fulai Jin, PhD
12p WRB Auditorium
|
|
|
 |
Cancer Center Seminar Series
January 10, 12p
WRB Auditorium
Our first cancer center seminar of 2020 features
Erika Trapl, PhD at noon today in the auditorium of the Wolstein Research Building.
Dr. Erika Trapl is an Associate Professor of Population and Quantitative Health Sciences and Associate Director of the
Prevention Research Center for Healthy Neighborhoods at Case Western Reserve University. She also serves as Co-Leader
of the Cancer Prevention, Control and Population Research Program for the Case Comprehensive Cancer Center.
On behalf of the Case CCC's Cancer Prevention, Control and Population Research Program, Dr. Trapl will present, "Tobacco Use in 2020: Why Tobacco Control Continues to be Critical for Cancer Prevention."
|
|
|
|
Cleveland Clinic Women's Health Institute Grand Rounds
January 14, 7a
CCLRI NA5-04
The Cleveland Clinic Gynecologic Oncology Research Program is excited to host
Kenneth Nephew, PhD from Indiana University Medical School at their upcoming research retreat on Monday, January 14.
Dr. Nephew is Professor of Anatomy, Cell Biology & Physiology whose major research interests include women’s cancer & translational research, cancer epigenetics, cancer stem cells, nuclear receptors/steroid hormone action-associated cancers and drug resistance (ovarian and breast cancer). Dr. Nephew will be presenting at the Cleveland Clinic Women’s Health Institute Grand Rounds on Wednesday, January 15th at 7:00am at the Lerner Research Institute in room NA5-04.
Dr. Nephew’s presentation is entitled “Leveraging Epigenetics to Enhance Therapeutics for Gynecologic Cancers”. All are welcome to attend.
|
|
|
|
|
Cancer Center Seminar Series
January 17, 12p
WRB Auditorium
Next week's cancer center seminar will be presented by
Michel Tremblay, PhD on behalf of the GI Cancer Genetics Program.
Dr. Tremblay is the James McGill Distinguished Professor and Jeanne and J. -Louis Levesque Chair in Cancer Research at the Goodman Cancer Research Centre at McGill University. He is also Director of the McGill Regenerative Medicine Network and a fellow of the Royal Society of Canada.
He will present, “Understanding Tyrosine Phosphatases Toward their Application in Cancer Therapeutics” at noon in the WRB Auditorium.
|
|
|
|
Cancer Center Special Seminar
January 22, 4p
WRB 2-136
All are welcome to attend a special cancer center seminar on Wednesday, January 22 at 4 pm in Wolstein Research Building conference room 2-136.
Ksenia Matlawska-Wasowska, PhD is an assistant professor of pediatrics, division of hematology-oncology at the University of New Mexico. She will present, "SOCS5 as a Novel Regulator of T-cell Lineage Acute Lymphoblastic Leukemia Progression and Dissemination."
|
|
|
|
|
4th Annual Cancer Disparities Symposium
March 6, 2020
Tinkham Veale University Center
The Case Comprehensive Cancer Center Office of Cancer Disparities Research will present the
4th Annual Cancer Disparities Symposium
: Cultivating Science and Community Engagement to Address Cancer Health Disparities on March 6, 2020.
The
agenda is now posted and will feature sessions on Cancer Disparities and Underserved Populations, Community Engagement and Support Programs, and Cancer Disparities Research and Community Engagement, plus invited presentations selected from standout abstract submissions. Keynote talks from
Robert T. Croyle, PhD from the National Cancer Institute and
Lucio Miele, MD, PhD from Louisiana State University cap-off the day's innovative agenda.
|
|
|
|
Save The Date: Cancer Stem Cell Conference 2020
August 4-6, 2020
Tinkham Veale University Center
The Case Comprehensive Cancer Center and the National Center for Regenerative Medicine invite you to save the date for CSC 2020! Now in its fourth year, CSC 2020 will feature renowned thought leaders in the field of cancer stem cell research. This conference is guaranteed to offer cutting-edge keynote presentations from a variety of niches within the field. Join world-class investigators for this three-day summit and network with scientists and clinicians advancing cancer stem cell research and therapeutic applications.
Registration will open in February 2020.
|
|
|
|
Additional Upcoming Events
|
|
|
ASH Review
January 22, 2020 5:15-6:45p
Intercontinental Hotel, Cleveland
|
This course will provide hematologists, medical oncologists, radiation oncologists and nurses with current data and information on topics presented at the American Society of Hematology 61st Annual Meeting in Orlando on December 7-10, 2019.
|
|
|
|
Breast Cancer Update: Review of Breast Cancer Symposia
February 12, 2020 11:45a-4:15p
Embassy Suites, Independence
|
This review course will summarize highlights from the national breast cancer meetings, with a focus on the clinical implications of the new information presented at these meetings. Medical oncologists, breast surgeons, radiation oncologists, women’s health, nurses, nurse practitioners, physician assistants, residents and fellows and other health care providers with an interest in the management of patients with breast cancer should attend this course.
|
|
|
|
|
2020 Multidisciplinary Head and Neck Cancer Update
February 14-15, 2020
Fort Lauderdale, FL
|
This course will provide practicing physicians, residents, fellows, and nurses in medical oncology, otolaryngology, radiation oncology, and head and neck surgery with a contemporary update of management strategies of head and neck cancer using a multidisciplinary approach. Lecture and panels will provide a forum for discussion of updated therapies and new treatment innovations.
|
|
|
|
NCCN 2020 Annual Conference
March 20-22, 2020
Orlando, FL
|
|
|
|
V Foundation Call for Pediatric Cancer Research Grants
Internal Deadline: January 20, 2020
Interested candidates should submit a one page LOI to
casecccpilots@case.edu by Monday, January 20 with the following:
- Title
- Brief description of proposed project
- Aims
|
|
Deadline: February 3, 2020
The Damon Runyon Clinical Investigator Award supports independent young physician-scientists conducting disease-oriented research that demonstrates a high level of innovation and creativity. The goal is to support the best young physician-scientists doing work aimed at improving the practice of cancer medicine.
The Clinical Investigator Award program is specifically intended to provide outstanding young physicians with the resources and training structure essential to becoming successful clinical investigators. The goal is to increase the number of physicians capable of moving seamlessly between the laboratory and the patient’s bedside in search of breakthrough treatments.
|
|
The Department of Defense's Congressionally Directed Medical Research Programs (CDMRP) recently released additional funding opportunities. Pre-application and application deadlines vary by award.
Breakthrough Award Levels 1 and 2
Pre-application deadline: March 12, 2020
Breakthrough Award Level 3
Pre-application deadline: March 13, 2020
Breakthrough Award Level 4
Pre-application deadline: March 13, 2020
Era of Hope Scholar Award
Pre-application deadline: March 12, 2020
Innovator Award
Pre-application deadline: March 13, 2020
|
|
Deadline: March 1, 2020
The William Guy Forbeck Research Foundation is looking for outstanding junior clinical or post-doctoral fellows to attend the Forbeck Forums.
During each meeting recipients of the award have an unrivaled opportunity to interact with international experts in their particular field of cancer research. Scholars may include post-doctoral fellows and clinicians in the early phases of their career. Independent investigators should be no further than their first 4 years of appointment.
In addition, award recipients will be invited to participate in the Foundation’s Scholar Retreats for the subsequent three years. This gives them further opportunities to interact with their peers and meet with different groups of international cancer experts. Existing awardees have found these interactions invaluable in developing collaborations as well as opening up a variety of career opportunities. Joining this group also offers awardees the opportunity of being able to apply for other programs sponsored by the Foundation that are only open to Forbeck Scholars.
|
|
Proposals Accepted on a Rolling Basis
Deadline: January 20, 2020
Proposals are accepted on a rolling basis subject to fund availability
Applications accepted and awarded on a rolling basis
Open until all 6 projects are awarded.
Open until all Phase I projects are awarded.
Deadlines: March 1, June 1, Sept 1, Dec 1
|
|
Cleveland.com - Dec 25, 2019
Siran Koroukian, PhD and
Nathan Berger, MD are co-authors of a study that suggests cancers associated with obesity are striking people at a younger age. The CWRU School of Medicine faculty are members of the Case CCC.
|
|
WKSU - Jan 2, 2020
Jill Barnholtz-Sloan, PhD is using statistics and math to help researchers untangle risk factors and survival factors for different types of brain tumors. Dr. Barnholtz-Sloan is Sally S. Morley Designated Professor in Brain Tumor Research at the CWRU School of Medicine and Associate Director for Data Sciences at the
Case CCC.
|
|
Weekly NIH Funding Opportunities and Notices
|
Notices
Funding Opportunities
Standard Dates Apply
|
|
Use the button below to submit all your news, events, announcements and communications requests to the Case CCC Marketing and Communications team!
|
|
|
|
|
|
|
